Henry Schein (HSIC) Stock

The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons to make the most of this tool.

Ananym Capital is urging Henry Schein to make some changes that could enhance the company's profits.

Ananym Capital Management, an activist investor, is pushing healthcare products distributor Henry Schein to update its board, reduce expenses, address succession planning, and think about selling its medical distribution division, according to sources familiar with the situation.

Henry Schein's stock rose over 4% during trading on Monday, aiming for its best performance since July. The financial company Gordon Haskett mentioned Robert F.

Henry Schein, Inc. (NASDAQ:HSIC) will hold its Q3 2024 Earnings Conference Call on November 5, 2024, at 10:00 AM ET. The call will feature company representatives including Graham Stanley, Stanley Bergman, and Ronald South, along with various conference call participants from different financial firms. Good morning to everyone, and welcome to the call; currently, all participants are in listen-only mode.

Henry Schein (HSIC) reported quarterly earnings of $1.22 per share, which is higher than the Zacks Consensus Estimate of $1.16 per share. However, this is lower than the earnings of $1.32 per share from the same period last year.

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein has announced its financial results for the third quarter of 2024 and has raised its financial expectations for the year.

To better understand how Henry Schein (HSIC) might perform in the quarter ending September 2024, look beyond Wall Street's basic profit and loss predictions. Instead, focus on the estimates for some of its important metrics. This will give you a clearer picture of the company's potential performance.

OKLAHOMA CITY--(BUSINESS WIRE)-- #FedermanSherwood--Federman & Sherwood is looking into a data breach involving Henry Schein, Inc.